Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources

ESMO Gynaecological Cancers Congress 2024

20 - 22 Jun 2024

Florence, Italy

ESMO-Gynaecological-Cancers-Congress-2024-1000x1000

Abstracts and ePosters: Open Access
Slides and Webcasts: Available to ESMO Members and registered delegates, subject to presenters' consent 

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

Meeting programme Next/upcoming meetings

The ESMO Gynaecological Cancers Congress 2024 provides insights into the diagnosis, biology and therapy of gynaecological malignancies, and updates on state-of-the-art expert management of patients with gynaecological cancers. The programme content highlights the scientific advances in profiling, risk stratification and innovative therapies for optimal care of these patients, with a focus on established and emerging biomarkers applicable for precision medicine and treatment selection.

All the resources are published!

Use the search box below to type any keywords, or the abstract number.

ESMO Colloquium supported by ImmunoGen - Platinum-resistant ovarian cancer: Biological pathways, resistance mechanisms and novel treatment options

Slides and Webcasts

Industry partners' Satellite Symposia

Watch the webcasts

Hide
Filter by:
Search:
Reset

There are 140 resources available

Panel discussion

Presenter: Andreia Fernandes

Session: GSK - Paradigm shifts and improving outcomes for patients with dMMR/MSI-H endometrial cancer

Resources:

Webcast

Panel discussion 2

Presenter: Andreia Fernandes

Session: GSK - Paradigm shifts and improving outcomes for patients with dMMR/MSI-H endometrial cancer

Resources:

Webcast

Q&A and closing remarks

Session: GSK - Paradigm shifts and improving outcomes for patients with dMMR/MSI-H endometrial cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.